Indication

Diphtheria-pertussis-tetanus-Haemophilus B vaccination

Diphtheria-pertussis-tetanus-Haemophilus B vaccination is a preventive immunization indicated for active protection in infants and young children against four distinct bacterial infections: diphtheria (caused by *Corynebacterium diphtheriae*), pertussis or whooping cough (caused by *Bordetella pertussis*), tetanus (caused by *Clostridium tetani*), and invasive disease caused by *Haemophilus influenzae* type b. Read more about Diphtheria-pertussis-tetanus-Haemophilus B vaccination

0 drugs 0 manufacturers

Drugs that treat it

Common Diphtheria-pertussis-tetanus-Haemophilus B vaccination therapies.

0 drugs

Sort

No drugs are available

This indication does not currently contain public drugs.

Filter & compare in the drug finder →Opens the drug finder with Diphtheria-pertussis-tetanus-Haemophilus B vaccination preselected.

News & literature

Coming soon

Related codes

Coming soon

About Diphtheria-pertussis-tetanus-Haemophilus B vaccination.

Diphtheria-pertussis-tetanus-Haemophilus B vaccination is a preventive immunization indicated for active protection in infants and young children against four distinct bacterial infections: diphtheria (caused by *Corynebacterium diphtheriae*), pertussis or whooping cough (caused by *Bordetella pertussis*), tetanus (caused by *Clostridium tetani*), and invasive disease caused by *Haemophilus influenzae* type b.

The target population is primarily pediatric, typically beginning in early infancy when individuals are most susceptible to life-threatening complications.

Pathophysiologically, these diseases involve respiratory tract obstruction and toxin-mediated systemic illness, intense tracheobronchial inflammation leading to paroxysmal spasms, neuromuscular toxin-mediated spastic rigidity, and invasive encapsulated bacterial spread manifesting as meningitis, bacteremia, epiglottitis, and pneumonia.